Aspect Biosystems

📍 Vancouver, Canada🗓 Founded 2013👥 149 employees💰 Last funded Jan 2020
Biotechnology Research🌐 aspectbiosystems.com
Website LinkedIn
Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders.
7
Total investors
1
Early stage
4
Mid stage
2
Late stage
2013
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
4
United States
3
Investor activity2015–2020 · investors recorded per year
2015120161201732019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aspect Biosystems?
Aspect Biosystems has 7 investors on record on gritt.io, including 1 early-stage backers, 4 mid-stage and 2 late-stage investors.
When did Aspect Biosystems last raise funding?
The most recent investment in Aspect Biosystems recorded on gritt.io was in January 2020.
When was Aspect Biosystems founded?
Aspect Biosystems was founded in 2013.
What industry is Aspect Biosystems in?
Aspect Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aspect Biosystems based?
Aspect Biosystems is headquartered in Vancouver, Canada.